If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Laura Arenare is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
trabectedin Medicine & Life Sciences
Platinum Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
letrozole Medicine & Life Sciences
zoledronic acid Medicine & Life Sciences
Nausea Medicine & Life Sciences
Vomiting Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2014 2019

  • 144 Citations
  • 7 h-Index
  • 22 Article
  • 1 Review article
2 Citations (Scopus)

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., Sep 1 2019, In : European Journal of Cancer. 118, p. 178-186 9 p.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Breast Neoplasms
Triptorelin Pamoate
Disease-Free Survival

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., 2019, In : European Journal of Cancer.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Breast Neoplasms
Triptorelin Pamoate
Disease-Free Survival

AXL is a novel predictive factor and therapeutic target for radioactive iodine refractory thyroid cancer

Collina, F., La Sala, L., Liotti, F., Prevete, N., La Mantia, E., Chiofalo, M. G., Aquino, G., Arenare, L., Cantile, M., Liguori, G., Di Gennaro, F., Pezzullo, L., Losito, N. S., Vecchio, G., Botti, G., Melillo, R. M. & Franco, R., Jun 1 2019, In : Cancers. 11, 6, 785.

Research output: Contribution to journalArticle

Open Access
Thyroid Neoplasms
Iodine
NF-kappa B
Oncogenes
Therapeutics
Biological Factors
Antineoplastic Agents
clinical trials
Clinical Trials
Costs and Cost Analysis

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

Morabito, A., Piccirillo, M. C., Maione, P., Luciani, A., Cavanna, L., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Morgillo, F., Burgio, M. A., Ferrara, D., Rosetti, F., Bianco, R., Artioli, F., Cortinovis, D., Gebbia, V., Fregoni, V., Mencoboni, M., Sandomenico, C. & 10 others, Rossi, A., Montanino, A., Manzo, A., Rocco, G., Arenare, L., Daniele, G., Signoriello, S., Gallo, C., Perrone, F. & Gridelli, C., Jul 1 2019, In : Lung Cancer. 133, p. 62-68 7 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cisplatin
Quality of Life
Drug Therapy
Mouth